UiPath combines high software quality — 156% free cash flow conversion, Rule of 40 of 48, and a Piotroski F-Score of 8/9 — with 31% short interest that creates a potential squeeze setup, though a death cross and negative asymmetry make this a watch rather than an add.
Thesis pillars
- Valuation Peg Discount↑Improving
- Exceptional Cash Conversion Quality→Stable
- Short Squeeze Potential→Stable
- +1 more pillar — see the Why tab for full reasoning
UiPath, Inc. (PATH) Stock Analysis
Recovery setup · Catalyst-Driven edge
Technology · Software - Infrastructure
Wait for pullback to $13.84. Recent C-suite change — blocks BUY_NOW at $16.03. Engine's entry $13.84 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: UiPath Platform; Analyst target reached - limited upside remaining.
UiPath develops the UiPath Platform, an enterprise automation and agentic AI software platform combining robotic process automation, AI agent orchestration, process intelligence, document processing, and governance tools for industries including financial services, healthcare,... Read more
Wait for pullback to $13.84. Recent C-suite change — blocks BUY_NOW at $16.03. Engine's entry $13.84 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: UiPath Platform; Analyst target reached - limited upside remaining. Chart setup: Death cross but MACD improving, RSI 79. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.3/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 20d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
About UiPath, Inc.
About UiPath, Inc.
UiPath served approximately 10,747 customers as of January 31, 2026, with substantially all revenue derived from the UiPath Platform—the company's single integrated automation and agentic AI product suite. The company holds 389 issued patents and 1,086 pending applications globally, including 131 AI-related issued patents expiring between 2039 and 2045. A limited number of customers represent a substantial portion of revenue and ARR, making customer concentration a disclosed material risk.
UiPath earns revenue through perpetual licenses, multi-year SaaS subscriptions via Automation Cloud, and professional services. The UiPath Platform spans five capability areas: Maestro (agentic orchestration and AI models), Robotic Process Automation (attended and unattended bots), Intelligent Document Processing (extraction and validation), Test Cloud (automated end-to-end testing), and vertical solutions for financial services, healthcare, and public sector. Revenue is generated through a direct enterprise sales force augmented by a channel partner network including global and regional system integrators. Two acquisitions expanded the platform in fiscal 2026: Peak (March 2025, demand forecasting and supply chain AI) and WorkFusion (February 2026, financial services automation). The company competes with a diverse set including ERP vendors, standalone RPA vendors, and hyperscaler AI native offerings.
Show full overview
Customer concentration is UiPath's most explicitly named structural dependency: the 10-K states that a limited number of customers represent a substantial portion of revenue and ARR, and that this revenue could decline significantly if those customers reduce or fail to renew. The company's voting structure further concentrates control—CEO Daniel Dines holds dual-class shares that represent a majority of combined voting power, meaning the outcome of shareholder votes on director elections, mergers, and governance matters is effectively predetermined by a single holder. Platform-level single-product dependency (substantially all revenue from UiPath Platform) and voting concentration compound the customer-concentration risk profile.
See also: Technology · Software - Infrastructure
From UiPath, Inc.'s most recent 10-K filing, extracted June 11, 2026.
Recent developments
updated 2026-08-15Recent Developments — UiPath, Inc.
Latest news
- NEWS If You Own Ui Path Stock... Watch This Video Before Thursday. Zachary Bolduc (xhHuLVi97m) - Mshale — Mshale neutral
- NEWS A Look Back at Automation Software Stocks’ Q4 Earnings: UiPath (NYSE:PATH) Vs The Rest Of The Pack - StockStory — StockStory neutral
- NEWS UiPath (PATH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance — Yahoo Finance neutral
- NEWS UiPath (PATH) Reports Earnings Tomorrow: What To Expect - FinancialContent — FinancialContent neutral
- NEWS UiPath (PATH) Reports Earnings Tomorrow: What To Expect - TradingView — TradingView neutral
Generated 2026-08-15T08:37:18Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductUiPath Platform10-K Item 1A: 'we derive substantially all of our revenue from our UiPath Platform™'
- MEDIUMCustomerlimited number of customers10-K Item 1A: 'A limited number of customers represent a substantial portion of our revenue and ARR'
Material Events(8-K, last 90d)
- 2026-03-25Item 5.02LOWCompensation Committee appointed Raghavendra Malpani, then serving as CTO, as Chief Product and Technology Officer effective March 25, 2026. No departure cited. Base salary set at $510,000 with 75% target annual bonus. Malpani previously held senior roles at Microsoft and Meta.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $13.84. Recent C-suite change — blocks BUY_NOW at $16.03. Engine's entry $13.84 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: UiPath Platform; Analyst target reached - limited upside remaining. Chart setup: Death cross but MACD improving, RSI 79. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $16.48 (+2.8%), stop $12.04 (−33.1%), A.R:R -1.7:1. Score 6.3/10, moderate confidence.
Take-profit target: $16.48 (-25.5% upside). Target $16.48 (+2.8%), stop $12.04 (−33.1%), A.R:R -1.7:1. Stop-loss: $12.04.
Concentration risk — Product: UiPath Platform; Analyst target reached - limited upside remaining; Overbought (RSI 79).
UiPath, Inc. trades at a P/E of 25.3 (forward 18.4). TrendMatrix value score: 6.3/10. Verdict: Buy (Wait for Entry).
28 analysts cover PATH with a consensus score of 3.4/5. Average price target: $13.
What does UiPath, Inc. do?UiPath develops the UiPath Platform, an enterprise automation and agentic AI software platform combining robotic...
UiPath develops the UiPath Platform, an enterprise automation and agentic AI software platform combining robotic process automation, AI agent orchestration, process intelligence, document processing, and governance tools for industries including financial services, healthcare, and manufacturing. The company served approximately 10,747 customers globally as of January 31, 2026, generating substantially all revenue from platform licenses and SaaS subscriptions sold through direct sales and channel partners.